BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37106467)

  • 1. COVID-19 cases reported in Colorado following screening at selected US airports, January - July 2020.
    Shaum A; Harlow T; Gulati RK; Berro A; House J
    BMC Res Notes; 2023 Apr; 16(1):67. PubMed ID: 37106467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Assessment and Management of COVID-19 Among Travelers Arriving at Designated U.S. Airports, January 17-September 13, 2020.
    Dollard P; Griffin I; Berro A; Cohen NJ; Singler K; Haber Y; de la Motte Hurst C; Stolp A; Atti S; Hausman L; Shockey CE; Roohi S; Brown CM; Rotz LD; Cetron MS; ; Alvarado-Ramy F
    MMWR Morb Mortal Wkly Rep; 2020 Nov; 69(45):1681-1685. PubMed ID: 33180758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Airport Traveler Testing Program for SARS-CoV-2 - Alaska, June-November 2020.
    Ohlsen EC; Porter KA; Mooring E; Cutchins C; Zink A; McLaughlin J
    MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(16):583-588. PubMed ID: 33886533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of fever screening at airports in detecting domestic passengers infected with SARS-CoV-2, 2020-2022, Okinawa prefecture, Japan.
    Takayama Y; Xu YS; Shimakawa Y; Chowell G; Kozuka M; Omori R; Matsuyama R; Yamamoto T; Mizumoto K
    BMC Infect Dis; 2024 May; 24(1):542. PubMed ID: 38816697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Predeparture Testing on Postarrival SARS-CoV-2-Positive Test Results Among International Travelers - CDC Traveler-Based Genomic Surveillance Program, Four U.S. Airports, March-September 2022.
    Bart SM; Smith TC; Guagliardo SAJ; Walker AT; Rome BH; Li SL; Aichele TWS; Stein R; Ernst ET; Morfino RC; Cetron MS; Friedman CR
    MMWR Morb Mortal Wkly Rep; 2023 Feb; 72(8):206-209. PubMed ID: 36821719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sectional survey of SARS-CoV-2 testing at US airports and one health department's proactive management of travelers.
    Shaum A; Figueroa A; Lee D; Ertl A; Rothney E; Borntrager D; Davenport E; Gulati RK; Brown CM
    Trop Dis Travel Med Vaccines; 2022 Mar; 8(1):8. PubMed ID: 35305682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Cases Reported on International Arriving and Domestic Flights: United States, January 2020-December 2021.
    Preston LE; Rey A; Dumas S; Rodriguez A; Gertz AM; Delea KC; Alvarado-Ramy F; Christensen DL; Brown C; Chen TH
    Am J Public Health; 2023 Aug; 113(8):904-908. PubMed ID: 37319391
    [No Abstract]   [Full Text] [Related]  

  • 9. Community exposures among Colorado adults who tested positive for SARS-CoV-2 -A case-control study, March-December 2021.
    White AE; Tran AD; Torok MR; Jervis RH; Albanese BA; Buchwald AG; Schmoll E; Stringer G; Herlihy RK; Scallan Walter EJ
    PLoS One; 2023; 18(3):e0282422. PubMed ID: 36862756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid review of the effectiveness of screening practices at airports, land borders and ports to reduce the transmission of respiratory infectious diseases such as COVID-19.
    Chetty T; Daniels BB; Ngandu NK; Goga A
    S Afr Med J; 2020 Oct; 110(11):1105-1109. PubMed ID: 33403987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Air travel and COVID-19 prevention in the pandemic and peri-pandemic period: A narrative review.
    Bielecki M; Patel D; Hinkelbein J; Komorowski M; Kester J; Ebrahim S; Rodriguez-Morales AJ; Memish ZA; Schlagenhauf P
    Travel Med Infect Dis; 2021; 39():101915. PubMed ID: 33186687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches - March-April 2020.
    Migisha R; Kwesiga B; Mirembe BB; Amanya G; Kabwama SN; Kadobera D; Bulage L; Nsereko G; Wadunde I; Tindyebwa T; Lubwama B; Kagirita AA; Kayiwa JT; Lutwama JJ; Boore AL; Harris JR; Bosa HK; Ario AR
    Global Health; 2020 Nov; 16(1):114. PubMed ID: 33239041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 molecular diagnosis at airports to minimize travel-related COVID-19 spread.
    de La Vega MA; Xiii A; Lee MF; Kobinger GP
    Sci Rep; 2022 Jul; 12(1):11753. PubMed ID: 35817815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and Risk of Coronavirus Disease 2019 Among Travelers at Airport and Port Quarantine Stations Across Japan: A Nationwide Descriptive Analysis and an Individually Matched Case-Control Study.
    Tsuboi M; Hachiya M; Ohtsu H; Akashi H; Miyoshi C; Umeda T
    Clin Infect Dis; 2022 May; 74(9):1614-1622. PubMed ID: 34318872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-collection and pooling of samples as resources-saving strategies for RT-PCR-based SARS-CoV-2 surveillance, the example of travelers in French Polynesia.
    Aubry M; Teiti I; Teissier A; Richard V; Mariteragi-Helle T; Chung K; Deen F; Paoaafaite T; Cao-Lormeau VM
    PLoS One; 2021; 16(9):e0256877. PubMed ID: 34473769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of international travel dynamics on domestic spread of 2019-nCoV in India: origin-based risk assessment in importation of infected travelers.
    Gunthe SS; Patra SS
    Global Health; 2020 May; 16(1):45. PubMed ID: 32398137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants Using Traveler-based Genomic Surveillance at 4 US Airports, September 2021-January 2022.
    Wegrzyn RD; Appiah GD; Morfino R; Milford SR; Walker AT; Ernst ET; Darrow WW; Li SL; Robison K; MacCannell D; Dai D; Girinathan BP; Hicks AL; Cosca B; Woronoff G; Plocik AM; Simen BB; Moriarty L; Guagliardo SAJ; Cetron MS; Friedman CR
    Clin Infect Dis; 2023 Feb; 76(3):e540-e543. PubMed ID: 35686436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passengers' destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America.
    Haider N; Yavlinsky A; Simons D; Osman AY; Ntoumi F; Zumla A; Kock R
    Epidemiol Infect; 2020 Feb; 148():e41. PubMed ID: 32100667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms and Characteristics Which Require Attention During COVID-19 Screening at a Port of Entry.
    Song SW; Kim D; Park JY; Lee S
    J Korean Med Sci; 2021 Jan; 36(2):e14. PubMed ID: 33429473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are rapid antigen SARS-Cov-2 tests effective for mass screening of travelers at airports? The Olympic experience.
    Torres JR
    J Travel Med; 2021 Oct; 28(7):. PubMed ID: 34480181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.